bristol-myers glp-1 receptor agonist products Repurposing glucagon-like peptide-1 agonists for the treatment of neurodegenerative disorders GLP-ONE + Receptor Activator |

About WashU Medicine WashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with more than 3,000 faculty

4,5 TABLE 1 provides a summary of key characteristics of currently available injectable GLP-1 receptor agonists

doi: 10.1530/EJE-22-0518 23 OReillyMWKempegowdaPJenkinsonCTaylorAEQuansonJLStorbeckK-Het al

January 15, 2026: Strive Specialties Accuses Trulicitys Maker of Blocking Patients from Low-Cost, Customized GLP-1s Strive Specialties is a compounding drug company that makes low-cost, customized versions of medications, and it helped formulate some GLP-1s during past shortages

Working with a provider whose background is in gastrointestinal health can be particularly beneficial, since many of GLP-1s benefits and side effects affect the digestive tract

Tirzepatide is expected to register the highest CAGR of approximately 12.5% during 2026-2035